The Director of Sanitary Emergencies of the World Health Organization (OMS), Mike Ryan, underlined that he was more than a hundred years old and started the vacancies, while continuing the media prevention efforts of the new covid- 19 podrían llegar.
“It’s not the time to talk to the media, we’re taking the risk of having a new case,” Ryan said, noting that last week the global contagious number dropped to 7%, followed by six weeks of descent.
The Irish expert insists that the antidote lure now has three fundamental pillars – individual mediation prevention, public health vigilance and vacancies – and that only the three work at the time “we can conclude that there are no confinements.
“Falling into one of them, we will take social media on a large scale”, Ryan warned in the OMS expert meeting with Internet users, through social media.
“Keep in mind that all of them are safe and sound, but the control is in our hands, we will get to the end of the tunnel”, underlined the head of emergency services of the OMS.
Ryan details that 115 countries started the vacancies and administered 265 million doses on the planet, including distribution and desigual, and 80 per cent of them were used in those countries alone (between the EU, China the United Kingdom, which holds the absolute numbers of munitions).
The expert also recorded and celebrated with a grand announcement in the antiquated window the commencement of the distribution of vacancies during the red solidarity COVAX, which since last week has sent 10 million doses to a decade of peace, between them Colombia, Ghana, Costa de Marfil or Corea del Sur.
The person in charge of the antiquities unit of the OMS, Maria Van Kerkhove, mentioned in the same way a virtual encounter with the preoccupation against the pandemic generating the new variants of the coronavirus (one of them, the British, is present in more than a centenary of lands).
Without embarrassment, the state of the nation has now approved that habitual contraceptives (avoiding competing places, mascara, hand hygiene) also work against these new varieties, first-time patients in the United Kingdom, South Africa and Brazil.